Forensic · SMMT
Summit Therapeutics
No signals triggered in our 36-month window. Most stable large-caps look like this. The $9 report still gets you the full chronology of every filing scanned + a clean-record audit trail.
Bear case preview · free
Summit Therapeutics Inc. (SMMT) registered a 0/100 LOW score because the 36-month SEC filing scan detected zero material adverse events across the monitored risk categories: no bankruptcy filings, financial restatements, exchange delistings, C-suite departures, equity dilution events, or disclosed cyber incidents. The company's regulatory filing cadence remained consistent with standard Nasdaq requirements, and no Form 8-K urgent event disclosures flagged executive turnover, debt defaults, or operational disruptions during the review window. Material changes to this score would require identification of any of the above triggering events in upcoming quarterly or annual filings, or disclosure of previously unreported material weakness in internal controls.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
0 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
0 S-3 + 424B5 filings
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on SMMT
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on SMMT + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.